Company / R&D Expense
Definitive Healthcare Corp. R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$42.4M
FY2025
5-year range
$4.0M / $42.4M
FY2021-FY2025
Trend
+21.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 4 consecutive years, from $4M in FY2021 to $42M in FY2025.
Based on SEC 10-K filings.
$42M in FY2025 with a 3-year CAGR of +56.5%.
Improved from $19M to $42M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +56.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Definitive Healthcare Corp.'s r&d expense has grown for 4 consecutive years.
- 3-year CAGR of +56.5%, indicating consistent growth.
- In FY2025, r&d expense increased 21.6% year-over-year.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.4M | +21.6% |
| FY2024 | $34.9M | +87.9% |
| FY2023 | $18.6M | +67.8% |
| FY2022 | $11.1M | +179.3% |
| FY2021 | $4.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026